View By Speaker
Marc Agronin, MD
M. Alexander, PhD, MA
S. Ancoli-Israel, Ph.D
L. Boesky, PhD
R. Brown, PhD
A. Burstein, MD
R. Dougherty, PhD
J. Draud, MD, MS
P. Earley
G. Emslie, MD
L. Ereshefsky, PharmD
M. Forstein, MD
A. Frances, MD
M. Gold, MD
D. Goodman, MD
K. Gray, MD
D. Greenberg, MD
D. Greydanus, MD
R. Hendren, DO
R. Jackson, MD
R. Jain, MD, MPH
S. Jain, PsyD, LPC, MBA
J. Kane, MD
S. Katz, MSN PMH-CNS, BC
L. Kinsella, MD, FAAN
A. Krystal, MD
S. Levine, MD
J. Maldonado, MD
V. Maletic, MD, PA
B. McCarberg, MD
J. McGough, MD, MS
L. Miller, MD
L. Nagy, MD
H. Nasrallah, MD
S. Negi, MA, PhD
J. Nelson, MD
J. Newcomer, MD
G. Papakostas, MD
M. Piasecki, MD
J. Prince, MD
C. Raison, MD
P. Resnick, MD
A. Robb, MD
C. Rodgers, MD
M. Rosenberg, MD, PhD
J. Schim, MD
D. Schuyler, MD
S. Shea, MD
T. Simpatico, MD
T. Skale, MD
B. Smith, JD
T. Smith, MS Psych, PD, FASCP, LMHC, NCP
S. Sobel, MD
D. Sprague
M. Stein, MD, MPH
R. Stille, MBA
V. Strasburger, MD
J. Tsuang, MD
S. Verma, MD
J. Victoroff, MD, MA
J. Weiner, MD, PhD
S. Yaffe, MD
A. Young, MD, MSHS
|
Marc Agronin, MDDirector, Mental Health Services, Miami Jewish Home and Hospital for the Aged, Fla.; Associate Professor of Psychiatry,
University of Miami Miller School of Medicine
| Tuesday, November 3 07:45-09:00 a.m. |
211 - It's Not Always Alzheimer's: A Review of the Other Dementia Types Part 1 GP PD
- Room: Mandalay Bay Ballroom CD |
Marc Agronin, MD, Director, Mental Health Services, Miami Jewish Home and Hospital for the Aged, Fla.; Associate Professor of Psychiatry,
University of Miami Miller School of Medicine
|
Although close to 70% of all individuals with dementia suffer from Alzheimer's disease, there are still many other critically important subtypes of dementia that must be recognized by the clinician. This symposium will provide a broad definition of dementia and then focus on some of the most important medically-induced subtypes and how to recognize them. Subtypes to be covered include normal pressure hydrocephalus, dementias due to human prion diseases and HIV infection, traumatic brain injury, and dementias that result from toxic exposures such as to alcohol or heavy metals. After Participating in this activity participants will be able to: - Discuss the entire spectrum of non-Alzheimer dementia subtypes
- List what diagnostic signs point to a potential medically-induced form of dementia.
- Discuss diagnosis and treatment of the following dementia subtypes: A) Normal pressure hydrocephalus.
- Human prion diseases.
- HIV associated dementia.
- Dementia due to traumatic brain injury(e.g., dementia pugilistica).
- Dementia due to ETOH and other toxic exposures. F) Dementia due to neurodegenerative diseases (e.g., multiple sclerosis).
|
| Tuesday, November 3 10:45-12:00 p.m. |
236 - What Is Old? Therapeutic Strategies with the Older Client GP
1.25 credits - Room: Mandalay Bay Ballroom CD |
Marc Agronin, MD, Director, Mental Health Services, Miami Jewish Home and Hospital for the Aged, Fla.; Associate Professor of Psychiatry,
University of Miami Miller School of Medicine
|
The fastest growing age group in the country is individuals of 85 years and above. As a result, it is becoming increasingly common for therapists to work with a significant number of older clients. This symposium will provide a context for such work along with many therapeutic tools. The aging process will be described with a focus on changes in cognition and personality that are relevant to late-life psychopathology. The symposium will then jump right into the therapeutic setting, discussing the role of the therapist, the impact of countertransference and stigma, and an approach to the diagnostic interview and psychotherapy that is both practical and age-specific. Upon the completion of this activity participants will be able to: - Review the aging process and its relevance to cognition and personality throughout the life cycle.
- Describe age-specific challenges encountered in therapy.
- Discuss the role of countertransference and stigma when working with older client.
- Apply Learn practical psychotherapeutic modalities in later life patients.
|
|
